Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.

Deng L, Zhang J, Wu T, Lawrie TA.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD005196. doi: 10.1002/14651858.CD005196.pub4. Review.

PMID:
23440800
2.

Combination chemotherapy for high-risk gestational trophoblastic tumour.

Deng L, Yan X, Zhang J, Wu T.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD005196. doi: 10.1002/14651858.CD005196.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD005196.

PMID:
19370618
3.

Combination chemotherapy for high-risk gestational trophoblastic tumour.

Xue Y, Zhang J, Wu TX, An RF.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005196. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD005196.

PMID:
16856085
4.

First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

Lawrie TA, Alazzam M, Tidy J, Hancock BW, Osborne R.

Cochrane Database Syst Rev. 2016 Jun 9;(6):CD007102. doi: 10.1002/14651858.CD007102.pub4. Review.

PMID:
27281496
5.

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.

Cochrane Database Syst Rev. 2016 Jan 13;(1):CD008891. doi: 10.1002/14651858.CD008891.pub3. Review.

PMID:
26760424
6.

First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD007102. doi: 10.1002/14651858.CD007102.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(6):CD007102.

7.

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008891. doi: 10.1002/14651858.CD008891.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;1:CD008891.

PMID:
23235667
8.

First line chemotherapy in low risk gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Hancock BW, Osborne R.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007102. doi: 10.1002/14651858.CD007102.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD007102.

PMID:
19160319
10.

Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.

Fu J, Fang F, Xie L, Chen H, He F, Wu T, Hu L, Lawrie TA.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD007289. doi: 10.1002/14651858.CD007289.pub2. Review.

PMID:
23076934
11.

Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.

Gulia S, Bajpai J, Gupta S, Maheshwari A, Deodhar K, Kerkar RA, Seth V, Rekhi B, Menon S.

Clin Oncol (R Coll Radiol). 2014 Jan;26(1):39-44. doi: 10.1016/j.clon.2013.08.010. Epub 2013 Sep 17.

PMID:
24051171
12.
13.

Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.

Lurain JR, Schink JC.

J Reprod Med. 2012 May-Jun;57(5-6):219-24.

PMID:
22696816
14.

Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.

Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, Kose MF.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1432-8.

PMID:
16803542
15.

Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.

Even C, Pautier P, Duvillard P, Floquet A, Kerbrat P, Troalen F, Rey A, Balleyguier C, Tazi Y, Leary A, Augereau P, Morice P, Droz JP, Fizazi K, Lhommé C.

Eur J Cancer. 2014 Aug;50(12):2082-9. doi: 10.1016/j.ejca.2014.05.002. Epub 2014 Jun 5.

PMID:
24910417
16.

EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.

Alifrangis C, Agarwal R, Short D, Fisher RA, Sebire NJ, Harvey R, Savage PM, Seckl MJ.

J Clin Oncol. 2013 Jan 10;31(2):280-6. doi: 10.1200/JCO.2012.43.1817. Epub 2012 Dec 10.

17.

Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.

Kim SJ, Bae SN, Kim JH, Kim CT, Han KT, Lee JM, Jung JK.

Int J Gynaecol Obstet. 1998 Apr;60 Suppl 1:S85-96.

PMID:
9833620
19.

Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia.

Chu MM, Ma Y, Tse KY, Chan KK, Ngan HY.

Int J Gynecol Cancer. 2015 Mar;25(3):498-503. doi: 10.1097/IGC.0000000000000383.

PMID:
25628108
20.

Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.

Fülöp V, Szigetvári I, Szepesi J, Végh G, Singh M, Berkowitz RS.

J Reprod Med. 2012 Jul-Aug;57(7-8):310-8.

PMID:
22838247
Items per page

Supplemental Content

Write to the Help Desk